Sommergruber, Wolfgang
Boehringer Ingelheim (Austria)
5 papers on CoChat
Most cited papers
- Verified
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
Hilberg, F., Roth, G. J., Krssak, M., Kautschitsch, S., Sommergruber, W., Tontsch-Grunt, U., Garin-Chesa, P., Bader, G., Zoephel, A., Quant, J., et al. (2008) · Cancer Research
Angiogenesis and VEGF in CancerLymphatic System and Diseases
Cited by 1,056
- Verified
Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery
Stock, K., Estrada, M. F., Vidic, S., Gjerde, K., Rudisch, A., Santo, V. E., Barbier, M., Blom, S., Arundkar, S. C., Selvam, I., et al. (2016) · Scientific Reports
3D Printing in Biomedical ResearchCancer Cells and Metastasis
Cited by 253
- Verified
3D-3-culture: a tool to unveil macrophage plasticity in the tumour microenvironment
Rebelo, S. P., Pinto, C., Martins, T. R., Harrer, N., Estrada, M. F., Loza-Alvarez, P., Cabeçadas, J., Alves, P. M., Gualda, E. J., Sommergruber, W., et al. (2018) · Biomaterials
Immune cells in cancerCancer Cells and Metastasis
Cited by 227
- Verified
Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescence
HAMPEL, B., FORTSCHEGGER, K., RESSLER, S., CHANG, M., UNTERLUGGAUER, H., BREITWIESER, A., SOMMERGRUBER, W., FITZKY, B., LEPPERDINGER, G., & JANSENDURR, P. (2006) · Experimental Gerontology
Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms
Cited by 78
- Verified
Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling
Jacobi, N., Seeboeck, R., Hofmann, E., Schweiger, H., Smolinska, V., Mohr, T., Boyer, A., Sommergruber, W., Lechner, P., Pichler-Huebschmann, C., et al. (2017) · Oncotarget
HER2/EGFR in Cancer ResearchCancer Cells and Metastasis
Cited by 43
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free